After another dismal quarter for Novo Nordisk A/S shares, investors are looking to an experimental treatment of the most common form of dementia to help spark a revival. The Danish drugmaker is ...

Morgan Stanley analyst Thibault Boutherin pointed to slowing momentum in U.S. prescriptions for Novo's flagship GLP-1 drugs, the weight-loss treatment Wegovy and type 2 diabetes therapy Ozempic. He ...

The Suunto Race 2 is a fantastic hardware upgrade, solidifying the brand's impressive comeback in recent years. The larger AMOLED display is stunning, the battery life is outstanding, and the GPS ...

Novo Nordisk has recently encountered headwinds in its core therapeutic area. The company has implemented changes that could pay off in the long run. Novo Nordisk's shares look reasonably valued. With ...

COPENHAGEN, Sept 17 (Reuters) - A senior Novo Nordisk (NOVOb.CO), opens new tab executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for treatment of ...

Berenberg Bank just upgraded Novo Nordisk to a buy. The banker believes investor expectations have reset and it's now possible Novo Nordisk has fallen enough to bounce again. Novo Nordisk (NYSE: NVO)- ...

Novo Nordisk A/S plans to seek US regulatory approval for a high-dose version of its blockbuster weight-loss shot Wegovy, another effort to counter Eli Lilly & Co. in the booming obesity market.

Attorney General Pam Bondi pledges to go after "hate speech," saying there's no place for it after Charlie Kirk’s assassination. But that isn't U.S. law under the First Amendment, and Kirk himself ...

Novo Nordisk A/S's stock is severely oversold as the market overreacts to short-term news, which has created what appears to be a rare buying opportunity. While Q2 guidance was lowered, the underlying ...

One day after announcing plans to cut 9,000 jobs in a major restructuring, Novo Nordisk has told its employees that office work will be mandatory at the start of next year. There is some flexibility ...

The entrance to one of Novo Nordisk’s two manufacturing facilities in Clayton, North Carolina on June 24, 2024. Brian Gordon [email protected] The Danish drugmaker Novo Nordisk announced ...

Layoffs: Ozempic-maker Novo Nordisk is set to lay off 9,000 employees across roles. Layoffs: Wegovy-maker, Novo Nordisk, has revealed plans on Wednesday to eliminate 9,000 employees as part of a ...